RIPK3 and Patent ductus arteriosus: It has been shown that downregulation of RIP3 in pancreatic ductal adenocarcinoma (PDA) can increase lymphocyte infiltration and eliminate immune tolerance so that the necroptosis may promote the occurrence of PDA through inducing immunosuppression [19].